Ursprung des Netzwerks ersten Grades von Brian Mangal
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 12 | |
Biostatistics & Research Information Systems
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Brian Mangal
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CGX ENERGY INC. | Oil & Gas Production | Director of Finance/CFO Public Communications Contact | |
| FORRESTER METALS INC | Other Metals/Minerals | Director/Board Member Investor Relations Contact | |
Trelawney Mining & Exploration, Inc.
 Trelawney Mining & Exploration, Inc. Precious MetalsNon-Energy Minerals Trelawney Mining & Exploration, Inc. mines for gold and other miscellaneous minerals. The firm's current focus is the exploration and development of the Côté Lake Gold Deposit in the Swayze Greenstone Belt, located halfway between Timmins and Sudbury. The company was founded on July 4, 1996 and is headquartered in Toronto, Canada. | Precious Metals | Director/Board Member Corporate Secretary | |
Zacoro Metals Corp.
 Zacoro Metals Corp. Precious MetalsNon-Energy Minerals Zacoro Metals Corp. mines and explores for gold and other metals. It engages in the mining of copper, gold, and zinc. The company is located in Toronto, Canada | Precious Metals | Director of Finance/CFO Corporate Secretary | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| TALISKER RESOURCES LTD. | Precious Metals | Director/Board Member Corporate Secretary | |
| WINDFALL GEOTEK INC. | Precious Metals | Director/Board Member | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| McMaster University | College/University | Undergraduate Degree | |
| QUINCY ENERGY CORP. | Other Metals/Minerals | Director of Finance/CFO | |
Sunovion CNS Development Canada Ulc
 Sunovion CNS Development Canada Ulc Pharmaceuticals: MajorHealth Technology Sunovion CNS Development Canada Ulc develops pharmaceuticals products. The company is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director/Board Member | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Director/Board Member | |
| TITAN MEDICAL INC. | Medical Specialties | Director/Board Member | |
| POND TECHNOLOGIES HOLDINGS INC. | Pharmaceuticals: Other | Director/Board Member | |
| MICROBIX BIOSYSTEMS INC. | Biotechnology | Director/Board Member | |
PNO Resources Ltd.
 PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | President | |
Neurotrophic Bioscience, Inc.
 Neurotrophic Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Neurotrophic Bioscience, Inc. develops pharmaceutical products. | Pharmaceuticals: Major | President | |
Valo Therapeutics Oy
 Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
| NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| International Institute for Management Development | College/University | Masters Business Admin | |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Calgary | College/University | Doctorate Degree | |
| TRILLIUM THERAPEUTICS | Biotechnology | Founder | |
| NUBIAN RESOURCES LTD. | Precious Metals | Corporate Secretary | |
| AVALON ADVANCED MATERIALS INC. | Other Metals/Minerals | Corporate Secretary | |
Elko Energy, Inc.
 Elko Energy, Inc. Oil & Gas ProductionEnergy Minerals Elko Energy, Inc. explores oil and gas wells. The company was founded in 2005 and is headquartered in Toronto, Canada. | Oil & Gas Production | Corporate Secretary | |
| CANDAX ENERGY INC | Oil & Gas Production | Corporate Secretary | |
| Immunoflex Therapeutics, Inc. | Chief Tech/Sci/R&D Officer | ||
Kalgene Pharmaceuticals, Inc.
 Kalgene Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Kalgene Pharmaceuticals, Inc. develops and focuses on personalized cancer diagnostics and drugs. It offers drugs for epithelial and thyroid cancers. The firm's oncology programs are aimed at improving clinical and survival outcomes through the use of personalized medicine, with a particular focus on bladder, epithelial and thyroid cancers. It serves the biopharmaceutical, research and development and health industries. The company is headquartered in Kingston, Canada. | Medical/Nursing Services | Chairman | |
| Eisai Medical Research, Inc. | Chief Tech/Sci/R&D Officer | ||
| ROCKWELL MEDICAL, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
ChemDiv, Inc.
 ChemDiv, Inc. Miscellaneous Commercial ServicesCommercial Services ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| McGill University | College/University | Doctorate Degree | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INSULET CORPORATION | Medical Specialties | Sales & Marketing | |
Vifor Pharma, Inc.
 Vifor Pharma, Inc. Medical/Nursing ServicesHealth Services Vifor Pharma, Inc. is an American company that specializes in iron deficiency, nephrology, and cardio-renal therapies. The company is based in Redwood. | Medical/Nursing Services | President | |
| RELYPSA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Chief Operating Officer | |
| Bryant University | College/University | Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Kanada | 35 |
| Vereinigte Staaten | 14 |
| Irland | 2 |
| Finnland | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 25 |
| Non-Energy Minerals | 10 |
| Consumer Services | 7 |
| Energy Minerals | 5 |
| Commercial Services | 4 |
Operativ
| Director/Board Member | 45 |
| Director of Finance/CFO | 40 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 19 |
| President | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jim Fairbairn | 45 |
| Paul van Damme | 26 |
| Anthony Giovinazzo | 22 |
| Charlotte May | 11 |
| Raymond Pratt | 11 |
| Patrick Treanor | 10 |
| David MacDonald | 8 |
| William Farley | 8 |
| Stephen Haworth | 6 |
| Allen Davidoff | 5 |
| Stacy Evans | 3 |
| James Boyett | 1 |
| Nick Rigopulos | 1 |
- Börse
- Insiders
- Brian Mangal
- Unternehmensverbindungen